bezafibrate has been researched along with Glycogen Storage Disease Type I in 1 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 1 (100.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Brooks, ED; Grant, S; Huat, BB; Koeberl, DD; Kudo, T; Landau, DJ; Lim, A; Waskowicz, LR; Wu, Y; Yavarow, ZA; Yen, PM; Young, SP; Zhang, H; Zhou, J | 1 |
1 other study(ies) available for bezafibrate and Glycogen Storage Disease Type I
Article | Year |
---|---|
Bezafibrate induces autophagy and improves hepatic lipid metabolism in glycogen storage disease type Ia.
Topics: Animals; Autophagy; Bezafibrate; Disease Models, Animal; Dogs; Glucose; Glucose-6-Phosphatase; Glucose-6-Phosphate; Glycogen; Glycogen Storage Disease Type I; Lipid Metabolism; Liver; Mice; Mice, Knockout; Triglycerides | 2019 |